Taylor Devices, INC
Market Movers (8-K)
NASDAQ
Taylor Devices, Inc. shareholders approved the 2025 Stock Option Plan, along with the election of a director and ratification of auditors, at their annual meeting on October 17, 2025.
Delay expected
NASDAQ
Alan R. Klembczyk, President of Taylor Devices, Inc., has announced his retirement effective June 1, 2025, and will not seek re-election to the board at the 2025 annual meeting.
NASDAQ
Taylor Devices, Inc. held its 2024 Annual Meeting of Shareholders, where all management proposals were approved, including the election of two directors and the ratification of the company's accounting firm.
NASDAQ
Taylor Devices, Inc. held its 2024 Annual Meeting of Shareholders on October 25, 2024, where all management proposals were approved.
Quarterly Earnings (10-Q)
NASDAQ
Taylor Devices, Inc. announced a significant increase in net income and earnings per share for its third fiscal quarter and nine-month period, despite a notable decrease in backlog.
Better than expected
NASDAQ
Taylor Devices, Inc. reported significant increases in net revenue and net income for the second fiscal quarter, driven by strong domestic sales, despite a notable decrease in backlog.
Better than expected
NASDAQ
Taylor Devices, Inc. reported a 15% decrease in net revenues and an 18% drop in net income for the first fiscal quarter ended August 31, 2025, compared to the prior year.
Worse than expected
NASDAQ
Taylor Devices, Inc. reports a decrease in net revenue and net income for the third quarter of fiscal year 2025 compared to the same period last year, while backlog increases slightly.
Worse than expected
NASDAQ
Taylor Devices experienced a slight decrease in net revenue and net income for the six months ended November 30, 2024, with a notable shift in sales concentration between domestic and international markets.
Worse than expected
NASDAQ
Taylor Devices, Inc. announced a significant increase in net sales and net income for the first quarter of fiscal year 2025, driven by growth in aerospace/defense and industrial sectors.
Better than expected
Annual Reports (10-K)
NASDAQ
Taylor Devices, Inc. announced a 5% increase in net income for fiscal year 2025, driven by higher revenues, despite a decrease in sales backlog.
NASDAQ
10-K: Taylor Devices Inc. Reports Strong Fiscal Year 2024 Results with Increased Revenue and Net Income
Taylor Devices, Inc. reports an 11% increase in net revenue and a 43% increase in net income for the fiscal year ended May 31, 2024, driven by growth in aerospace/defense sales and improved gross margins.
Better than expected
Insider Trading (Form 4)
NASDAQ
Taylor Devices, Inc. reports that CEO Timothy J. Sopko acquired 7,000 stock options on April 18, 2026.
NASDAQ
Taylor Devices, Inc. director Robert Michael Carey has acquired 7,000 stock options.
NASDAQ
Taylor Devices, Inc. reports that Chief Financial Officer Paul Murray Heary acquired 7,000 stock options.
NASDAQ
Director John Burgess of Taylor Devices, Inc. acquired 7,000 stock options on April 18, 2026, with an exercise price of $56.43.
NASDAQ
Fritz Eric Armenat, a Director at Taylor Devices, Inc., acquired stock options for 7,000 shares.
NASDAQ
Director John Burgess of Taylor Devices, Inc. reported transactions involving the acquisition and disposition of common stock.
Proxy Statements (Def-14A)
NASDAQ
Taylor Devices, Inc. announced its 2025 Annual Meeting of Shareholders to be held on October 17, 2025, where shareholders will vote on director election, auditor ratification, and a new stock option plan.
NASDAQ
Taylor Devices, Inc. will hold its 2024 Annual Meeting of Shareholders on October 25, 2024, to elect directors and ratify the appointment of its independent accounting firm.
Schedule 13G - Passive Investments
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.16% of Taylor Devices Inc. common stock as of June 30, 2026.
NASDAQ
Wax Asset Management, LLC has reported a 9.4% beneficial ownership stake in Taylor Devices Inc. common stock.
NASDAQ
The Vanguard Group has updated its beneficial ownership in Taylor Devices Inc., reporting a 4.74% stake in the company's common stock as of June 30, 2025.
NASDAQ
Wax Asset Management, LLC has disclosed a significant 8.3% beneficial ownership stake in Taylor Devices Inc., holding 260,513 shares of common stock.
NASDAQ
The Vanguard Group has reported a 5.09% beneficial ownership stake in Taylor Devices Inc. common stock, held for investment purposes in the ordinary course of business.